Skip to content
A subvariant of Omicron by the name of BA.2.75.2 is the most recent strain of COVID-19 causing concern. This variant has already developed the […]
New Omicron subvariant could create challenges this fall Read More »
The Food and Drug Administration (FDA) on Thursday authorized a new medication intended to halt the progression of amyotrophic lateral sclerosis (ALS), also known
FDA approves new ALS drug funded partially by ‘Ice Bucket Challenge’ Read More »
In a monumental victory for the people in Oregon, biotech innovation, and the Biotechnology Innovation Organization (BIO), the Accelerated Approval pathway will be preserved
Oregon preserves Medicaid coverage for ‘Accelerated Approval’ drugs Read More »
An experimental Alzheimer’s drug developed by Biotechnology Innovation Organization’s (BIO) members Eisai Co Ltd and Biogen slowed the cognitive and functional decline in a
Eisai and Biogen’s Alzheimer’s drug slows cognitive decline, study shows Read More »
Almost 80% of patients hospitalized with COVID-19 from March 2020 to October 2020 received an antibiotic, even though less than 3% had any bacterial
Antibiotics misuse and overprescribing revisited ahead of expected fall COVID wave Read More »
The Centers for Disease Control and Prevention (CDC) carried out a national study which found that mRNA vaccines are safe during pregnancy. In addition,
Maternal vaccination still low despite proven mRNA safety Read More »
After the Uganda Virus Research Institute confirmed a case of the rare Sudan ebolavirus in a 24-year-old man in Mubende district, Uganda’s health authorities
New Ebola outbreak highlights need for vaccines, therapeutics Read More »
After making the misguided decision to waive intellectual property (IP) protections for COVID vaccines, the World Trade Organization (WTO) is thinking about extending the
BIO: Expanding COVID IP waiver could harm US biotech companies Read More »
Research teams from the Oregon State University and Oregon Health & Science University (OHSU) have made a major breakthrough: developing the first-ever mRNA therapy
Oregon State University develops mRNA therapy to treat ovarian cancer and cachexia Read More »
More people than ever before are living longer and fuller lives after a cancer diagnosis, the American Association for Cancer Research’s (AACR) 12th annual
Cancer survival rates in U.S. steadily increase, finds new AACR report Read More »
